Reliability and validity of point-of-care tests taken from urine samples of patients on therapy with Apixaban, Rivaroxaban and Dabigatran - Harenberg, J; Warttinger, U; Hetjens, S (Res Pract Thromb Haemost, 2017)
, et al.